SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-057263
Filing Date
2024-05-09
Accepted
2024-05-09 17:15:11
Documents
11
Period of Report
2024-05-05
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 8-K ktra-20240505.htm   iXBRL 8-K 56479
  Complete submission text file 0000950170-24-057263.txt   176259

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ktra-20240505.xsd EX-101.SCH 30542
14 EXTRACTED XBRL INSTANCE DOCUMENT ktra-20240505_htm.xml XML 4689
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 24931904
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)